Neovascular Retinal Disease: Examining Emerging Trends in Treatment

Event Information

Share this event

Date and Time



Hyatt Regency Chicago

151 East Wacker Drive

Plaza Ballroom; East Tower, Lobby Level

Chicago, Illinois 60601

View Map

Event description


This program is intended for ASRS attendees only.

Activity Chair

Rishi P. Singh, MD
Staff Physician, Cole Eye Institute
Medical Director, Clinical Systems Office
Cleveland Clinic
Associate Professor of Ophthalmology
Case Western Reserve University
Cleveland, OH


Nathan C. Steinle, MD
California Retina Consultants
Santa Barbara, CA

Charles C. Wykoff, MD, PhD
Retina Consultants of Houston
Blanton Eye Institute and
Houston Methodist Hospital
Houston, TX


The integration of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy into management protocols for the treatment of neovascular retinal disease has revolutionized patient outcomes. However, individualizing dosing schedules to maintain visual acuity gains can be challenging and burdensome to the patient. Furthermore, approximately two-thirds of patients receive a suboptimal response to anti-VEGF therapy, identifying a need for the discovery and classification of novel molecular pathways for targeted therapeutic intervention. In this live satellite symposium, experts will review the current evidence for the long-term efficacy of treatment and will discuss the mechanisms of novel therapies targeting alternative pathways as well as evaluate new evidence for emerging therapies that have the potential to reduce treatment frequency while optimizing visual acuity gains in patients with neovascular retinal disease.


12:50 PM
Registration and Lunch

1:05 PM
Introduction and Pretest
Rishi P. Singh, MD

1:10 PM
Targeting New Pathways in the Treatment of Neovascular Retinal Diseases
Charles C. Wykoff, MD, PhD

1:30 PM
Extending the Life of Treatment for Neovascular Retinal Disease – Emerging Options
Nathan C. Steinle, MD

1:50 PM
Wheel of Neovascular Retinal Disease Knowledge
With your host, Rishi P. Singh, MD

2:05 PM
Posttest and Question and Answer

2:10 PM

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Examine current evidence regarding the long-term efficacy of treatments for neovascular retinal diseases.

  • Assess the mechanisms of novel treatments for neovascular retinal diseases that target alternate pathways and those that offer medication delivery for extended periods of time.

  • Evaluate new evidence about emerging therapies that may improve the treatment of neovascular retinal diseases.

Target Audience

The intended audience for this activity is retina specialists and other health care professionals involved in the management of patients with neovascular retinal disease.

This continuing medical education activity is provided by Vindico Medical Education.

This activity is supported by an educational grant from Genentech, Inc.

This program is not affiliated with ASRS.

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support,all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

Faculty, topics, program schedule, and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program committee.

Share with friends

Date and Time


Hyatt Regency Chicago

151 East Wacker Drive

Plaza Ballroom; East Tower, Lobby Level

Chicago, Illinois 60601

View Map

Save This Event

Event Saved